Get the Stockscreener App
7.20
0.69%
-0.05
Exozymes Inc stock is traded at $7.20, with a volume of 2,268.
It is down -0.69% in the last 24 hours and down -20.00% over the past month.
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.
See More
Previous Close:
$7.25
Open:
$7.35
24h Volume:
2,268
Relative Volume:
0.60
Market Cap:
$60.48M
Revenue:
$70,100
Net Income/Loss:
$-8.34M
P/E Ratio:
-7.2311
EPS:
-0.9957
Net Cash Flow:
-
1W Performance:
+0.98%
1M Performance:
-20.00%
6M Performance:
-50.57%
1Y Performance:
-42.68%
1-Day Range:
$7.20
$7.35
1-Week Range:
$7.20
$7.50
52-Week Range:
$7.08
$18.40
Exozymes Inc Stock (EXOZ) Company Profile
Name
Exozymes Inc
Sector
Industry
Phone
(626) - 415 - 1488
Address
750 ROYAL OAKS DR, MONROVIA
Compare EXOZ vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EXOZ
Exozymes Inc
|
7.20 | 60.90M | 70,100 | -8.34M | 0 | -0.9957 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Exozymes Inc Stock (EXOZ) Latest News
eXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026 - Bitget
eXoZymes to release 2025 results before March 31 investor call - Stock Titan
EXOZ Price Today: eXoZymes Inc. Stock Price, Quote & Chart - mexc.co
Whale Trades: Can eXoZymes Inc sustain earnings growthRate Hike & High Accuracy Investment Entry Signals - baoquankhu1.vn
eXoZymes (NASDAQ:EXOZ) Shares Up 2.4%What's Next? - MarketBeat
Momentum Shift: Is eXoZymes Inc forming a bullish divergenceForecast Cut & Reliable Price Action Trade Plans - baoquankhu1.vn
If You Invested $1,000 in eXoZymes Inc (EXOZ) - Stock Titan
Growth Recap: Whats the beta of eXoZymes Inc stock2026 Top Decliners & Long-Term Safe Return Strategies - baoquankhu1.vn
Aug PostEarnings: What is eXoZymes Incs market positionEarnings Risk Summary & Fast Moving Trade Plans - baoquankhu1.vn
Whale Trades: Will eXoZymes Inc benefit from seasonality2026 Analyst Calls & Technical Pattern Based Signals - baoquankhu1.vn
Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability - ACCESS Newswire
Successful pilot scale run with Cayman Chemical validates eXoZymes' technology and scalability - SynBioBeta
Sell Signal: What are eXoZymes Incs recent SEC filings showing2026 Growth vs Value & Accurate Technical Buy Alerts - baoquankhu1.vn
eXoZymes’ CCO Damien Perriman to Present an NCT Solution at Next Week’s MISTA Symposium - The National Law Review
eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium - Bitget
The rare plant molecule eXoZymes is scaling for metabolic health - Stock Titan
Pullback Watch: Does eXoZymes Inc stock have upside surprise potentialJuly 2025 Rallies & Low Volatility Stock Recommendations - baoquankhu1.vn
Head-To-Head Analysis: eXoZymes (NASDAQ:EXOZ) & Curis (NASDAQ:CRIS) - Defense World
Latest EXOZ NewseXoZymes Launches Subsidiary, NCTx, to Unlo... - Stock Titan
Molecular Partners (NASDAQ:MOLN) and eXoZymes (NASDAQ:EXOZ) Head-To-Head Analysis - Defense World
With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value - EIN News
Is eXoZymes Inc backed by strong institutional buyingWeekly Profit Recap & Precise Trade Entry Recommendations - baoquankhu1.vn
Travel Stocks: Does eXoZymes Inc stock have upside surprise potentialJuly 2025 Big Picture & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Market Recap: Can Kearny Financial Corp withstand a market correctionJuly 2025 Sector Moves & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Algo Trading Space Launches Space Tracker: Advanced Trading Journal and Analytics Platform for VIP Members - MetroWest Daily News
Institution Moves: Is eXoZymes Inc a speculative investmentMarket Performance Report & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
EXOZ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Will eXoZymes Inc. stock continue upward momentumBond Market & Target Return Focused Picks - mfd.ru
Does eXoZymes Inc. stock reflect fundamentalsJuly 2025 Snapshot & Weekly Setup with High ROI Potential - mfd.ru
Does eXoZymes Inc. stock have upside surprise potentialSell Signal & Weekly Top Gainers Alerts - mfd.ru
eXoZymes unveils new website and branding to reflect pharma focus By Investing.com - Investing.com South Africa
Quarterly Earnings: What chart patterns are forming on eXoZymes IncMarket Risk Analysis & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
eXoZymes unveils new website and branding to reflect pharma focus - Investing.com
With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation - ACCESS Newswire
eXoZymes Reports Successful Pilot-Scale NCT Production Results - TipRanks
eXoZymes Inc Advances Commercial Readiness with NCT Pilot Run - TradingView
eXoZymes - Nasdaq
Critical Review: eXoZymes (NASDAQ:EXOZ) vs. Disc Medicine (NASDAQ:IRON) - Defense World
eXoZymes (NASDAQ:EXOZ) Trading Up 5.5%Here's Why - MarketBeat
Investment Report: Is eXoZymes Inc forming a bullish divergence2025 EndofYear Setup & Short-Term Trading Alerts - baoquankhu1.vn
Bond Watch: Will eXoZymes Inc benefit from current market trends2025 Top Gainers & Safe Swing Trade Setups - baoquankhu1.vn
Institution Moves: Can KMPR lead its sector in growthRisk Management & Community Consensus Trade Alerts - baoquankhu1.vn
eXoZymes Advances Commercial Readiness With Profound Production Metrics From Initial NCT Pilot Run - The National Law Review
Stock Recap: What is the long term forecast for ROIV stock2025 Momentum Check & Verified Swing Trading Watchlists - baoquankhu1.vn
Guidance Update: Can eXoZymes Inc sustain earnings growthJuly 2025 Closing Moves & Expert Curated Trade Ideas - baoquankhu1.vn
AI-enhanced enzymes yield pharma-grade NCT, ready for partner testing - Stock Titan
eXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run - galvnews.com
EXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run - 富途牛牛
Chipmakers Recap: Is ZIMV attractive at current valuationJuly 2025 Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
Aug Rallies: What is eXoZymes Incs market position2025 Market WrapUp & Weekly Return Optimization Alerts - baoquankhu1.vn
Merger Talk: Is BlackRock Innovation and Growth Term Trust impacted by rising ratesJuly 2025 Update & Expert-Curated Trade Recommendations - baoquankhu1.vn
Exozymes Inc Stock (EXOZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):